Table 1 Clinical & ultrasound imaging features of patient with IEPS.
Birth y | Prenatal ultrasound | Associated anomalies | Postnatal imaging | Treatment | Follow-up | |
|---|---|---|---|---|---|---|
1 | 2005 | 24 wk, L suprarenal mass; 30 wk, increased size from 2.7 × 2.3 to 4.2 × 3.3 cm | No | No | Abortion | — |
2 | 2006 | 21 wk, L suprarenal mass, 3.0 × 2.8 cm | DH | No | Abortion | — |
3 | 2007 | 21 wk, R suprarenal mass, 2.7 × 1.9 cm | No | US through 5 mo: 3.5 × 2.3 cm | Open surgery at 55 mo (2012) | Serial US through 55–67 mo (continue 12 mo), NED |
4 | 2008 | 26 wk, L suprarenal mass, 3.0 × 2.0 cm | DH | No | Abortion | — |
5 | 2009 | 25 wk, L suprarenal mass, 2.6 × 2.2 cm | No | US through 2 mo, CT through 20 mo: 3.5 × 3.0 cm | Open surgery at 45 mo (2013) | Serial US through 47–60 mo (continue 13 mo), NED |
6 | 2009 | 26 wk, L suprarenal mass, 3.5 × 3.0 cm | DH | No | Abortion | — |
7 | 2009 | 26 wk, L suprarenal mass, 4.0 × 3.0 cm | DA | No | Abortion | — |
8 | 2010 | 24 wk, L suprarenal mass 2.7 × 2.6 cm | DH | No | Abortion | — |
9 | 2010 | 23 wk, R suprarenal mass 4.6 × 2.9 cm | No | US through 4 mo, CT through 24 mo: 4.7 × 3.0 cm | Open surgery at 38 mo (2014) | Serial US through 38–50 mo (continue 12 mo), NED |
10 | 2011 | 21 wk, L suprarenal mass; 28 wk, increased size from 2.0 × 1.9 cm to 3.5 × 2.9 cm | No | No | Abortion | — |
11 | 2011 | 27 wk, L suprarenal mass; trisomy 18, 3.0 × 3.0 cm | AC & DH | No | Abortion | — |
12 | 2012 | 22 wk, L suprarenal mass 4.1 × 3.0 cm | No | US through 2 mo, CT through 16 mo: 4.7 × 3.5 cm | Open surgery at 25 mo (2014) | Serial US through 25–35 mo (continue 10 mo), NED |
13 | 2012 | 25 wk, R suprarenal mass 3.0 × 1.9 cm | No | US through 4 mo, CT through 6 mo: 4.2 × 2.9 cm | Open surgery at 24 mo (2014) | Serial US through 24–36 mo (continue 12 mo), NED |
14 | 2013 | 27 wk, L suprarenal mass 2.7 × 2.3 cm | No | US through 4 mo, MRI through 12 mo: 3.0 × 2.5 cm | LAP at 20 mo (2015) | Serial US through 20–31 mo (continue 11 mo), NED |
15 | 2013 | 22 wk, L suprarenal mass 3.2 × 3.1 cm | DH | No | Abortion | — |
16 | 2014 | 24 wk, L suprarenal mass 3.5 × 2.7 cm | No | US through 1 mo, MRI through 10 mo: 4.7 × 3.3 cm | LAP at 16 mo (2015) | Serial US through 16–26 mo (continue 10 mo), NED |
17 | 2015 | 26 wk, L suprarenal mass, 3.9 × 2.9 cm | No | US through 3 mo: 4.5 × 3.3 cm | LAP at 13 mo (2016) | Serial US through 14–25 mo (continue 11 mo), NED |
18 | 2015 | 25 wk, L suprarenal mass, 3.0 × 2.3 cm | No | US through 2 mo, 3.5 × 2.7 cm | LAP at 8 mo (2016) | Serial US through 8–19 mo (continue 11 mo), NED |
19 | 2016 | 24 wk, L suprarenal mass, 3.5 × 3.2 cm | No | US through 5 d, CT through 4 mo: 4.5 × 3.9 cm | LAP at 6 mo (2016) | Serial US through 6–15 mo (continue 9 mo), NED |
20 | 2016 | 29 wk, L suprarenal mass, 2.9 × 2.6 cm | No | US through 10 d, 3.0 × 2.8 cm | LAP at 3 mo (2016) | Serial US through 3–13 mo (continue 10 mo), NED |
21 | 2017 | 21 wk, L suprarenal mass, 3.0 × 2.4 cm | US through 7 d, MRI through 1 mo: 3.5 × 2.9 cm | LAP at 2 mo (2017) | Serial US through 2–3 mo (continue 1 mo), NED |
